Regeneron Pharmaceuticals signs 116,200 s/f expansion with BioMed Realty

Tarrytown, NY Regeneron Pharmaceuticals Inc. has signed a nine-year lease expansion with BioMed Realty Trust Inc. for 116,200 s/f at the Landmark at Eastview, bringing the campus to 99% leased. The life sciences company now leases 1.1 million s/f at The Landmark at Eastview campus. BioMed Realty was represented by Transwestern partner Matthew McDevitt in the transaction. “We are proud to extend our valued relationship with Regeneron Pharmaceuticals,” said BioMed’s Alan Gold, chairman and chief executive officer. “Transwestern is a highly regarded firm that we’ve had the pleasure of working with on a number of significant biotech transactions along the East Coast, and we are excited to continue working with them to build leasing momentum at The Landmark.” Owned and managed by BioMed Realty, The Landmark at Eastview is one of the largest multi-tenant science parks in the state. Peter Capuciati and Alex Blue of Savills Studley represented Regeneron Pharmaceuticals in the transaction.